OXID eSales erweitert Vorstand
Roland Fesenmayr (CEO) und Dr. Oliver Ciupke (COO) treiben das Geschäft des E-Commerce-Plattformherstellers zukünftig gemeinsam voran
Probiodrug announces completion of recruitment for the SAPHIR Phase 2a study of Glutaminyl Cyclase Inhibitor PQ912 in early Alzheimer's disease patients
NOXXON PHARMA SIGNS CLINICAL IMMUNO-ONCOLOGY COLLABORATION AGREEMENT WITH MSD TO STUDY NOX-A12 COMBINED WITH KEYTRUDA® (PEMBROLIZUMAB) IN PANCREATIC AND COLORECTAL CANCER